raloxifene hydrochloride has been researched along with Barrett Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fass, R; Hill, H; Liu, BD; Saleh, S; Song, G; Udemba, SC | 1 |
| Ansar, A; Hussey, DJ; Sukocheva, OA; Watson, DI; Wee, C | 1 |
2 other study(ies) available for raloxifene hydrochloride and Barrett Esophagus
| Article | Year |
|---|---|
Raloxifene increases the risk of gastroesophageal reflux disease, Barrett's esophagus, and esophageal stricture in postmenopausal women with osteoporosis.
Topics: Barrett Esophagus; Case-Control Studies; Cohort Studies; Esophageal Stenosis; Female; Gastroesophageal Reflux; Humans; Osteoporosis; Postmenopause; Raloxifene Hydrochloride; Risk Factors | 2023 |
Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Barrett Esophagus; Cadherins; Cell Count; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ki-67 Antigen; Male; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen | 2013 |